Novartis Wins Dutch Appeal To Keep Hypertension SPC
An appellate court in The Hague has rejected a Dutch company's attacks against a Novartis supplementary protection certificate extending exclusivity for a patented hypertension treatment, ruling that nobody had thought of...To view the full article, register now.
Already a subscriber? Click here to view full article